Endosense, a Swiss medical technology company, and Siemens Healthcare have agreed to commence a joint development project intended to integrate the contact-force data provided by Endosense's TactiCath force-sensing ablation catheter with Siemens' electrophysiology solutions.
The goal of the effort is to develop a technologically advanced, all-in-one software application that allows electrophysiologists to visualize catheter-tip-to-tissue contact force within a three-dimensional anatomic heart model during catheter ablation procedures.
Endosense CEO Eric Le Royer said the joint development project between Endosense and Siemens represents a very promising area of future advancement in the field of catheter ablation, as it will offer electrophysiologists a new platform for incorporating contact force sensing into clinical practice.
"An integrated, all-in-one system will deliver greater functionality and efficiency to EP labs, thereby moving Endosense another step toward our goal of improving and expanding catheter ablation for the treatment of cardiac arrhythmias. We look forward to collaborating with a respected, trend-setting company like Siemens to move this new platform forward," Royer said.
Endosense’ TactiSys system second generation device is used by electrophysiologists across Europe for the treatment of atrial fibrillation (AF) and supraventricular tachycardia (SVT).